Breaking: All Covid restrictions lifted for Brits travelling to Spain
All Covid-19 travel restrictions for people visiting Spain have been lifted. The UK government has advised that from today , the rules that were previously in place for travellers entering the country no longer apply, regardless of whether or not you have had Covid jabs.
It means if you're travelling to Spain, you don't have to prove that you are fully vaccinated any more. You don't need to provide a negative Covid test or show proof of having recovered from Covid in the last six months either. Holidaymakers are also no longer required to complete a health control form prior to travel. The entry requirements are the same for all travellers, both vaccinated and unvaccinated.The UK government updated its Spain travel advice this morning. It advises all travellers to make sure they understand all entry rules and travel advice that may apply before setting off.
Visit https://www.gov.uk/foreign-travel-advice/spain for all current Spain travel advice. If you're going to be passing through another country on your way to Spain or back to the UK, you should check the travel advice for those countries, too.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients - BMC MedicineBackground In view of accumulating case reports of thyroid dysfunction following COVID-19 vaccination, we evaluated the risks of incident thyroid dysfunction following inactivated (CoronaVac) and mRNA (BNT162b2) COVID-19 vaccines using a population-based dataset. Methods We identified people who received COVID-19 vaccination between 23 February and 30 September 2021 from a population-based electronic health database in Hong Kong, linked to vaccination records. Thyroid dysfunction encompassed anti-thyroid drug (ATD)/levothyroxine (LT4) initiation, biochemical picture of hyperthyroidism/hypothyroidism, incident Graves’ disease (GD), and thyroiditis. A self-controlled case series design was used to estimate the incidence rate ratio (IRR) of thyroid dysfunction in a 56-day post-vaccination period compared to the baseline period (non-exposure period) using conditional Poisson regression. Results A total of 2,288,239 people received at least one dose of COVID-19 vaccination (57.8% BNT162b2 recipients and 42.2% CoronaVac recipients). 94.3% of BNT162b2 recipients and 92.2% of CoronaVac recipients received the second dose. Following the first dose of COVID-19 vaccination, there was no increase in the risks of ATD initiation (BNT162b2: IRR 0.864, 95% CI 0.670–1.114; CoronaVac: IRR 0.707, 95% CI 0.549–0.912), LT4 initiation (BNT162b2: IRR 0.911, 95% CI 0.716–1.159; CoronaVac: IRR 0.778, 95% CI 0.618–0.981), biochemical picture of hyperthyroidism (BNT162b2: IRR 0.872, 95% CI 0.744–1.023; CoronaVac: IRR 0.830, 95% CI 0.713–0.967) or hypothyroidism (BNT162b2: IRR 1.002, 95% CI 0.838–1.199; CoronaVac: IRR 0.963, 95% CI 0.807–1.149), GD, and thyroiditis. Similarly, following the second dose of COVID-19 vaccination, there was no increase in the risks of ATD initiation (BNT162b2: IRR 0.972, 95% CI 0.770–1.227; CoronaVac: IRR 0.879, 95%CI 0.693–1.116), LT4 initiation (BNT162b2: IRR 1.019, 95% CI 0.833–1.246; CoronaVac: IRR 0.768, 95% CI 0.613–0.962), hyperthyroidism (BNT162b2: IRR 1.0
Lire la suite »
Time series cross-correlation between home range and number of infected people during the COVID-19 pandemic in a suburban cityControl of human mobility is one of the most effective measures to prevent the spread of coronavirus disease 2019 (COVID-19). However, the imposition of emergency restrictions had significant negative impacts on citizens’ daily lives. As vaccination progresses, we need to consider more effective measures to control the spread of the infection. The research question of this study is as follows: Does the control of home range correlate with a reduction in the number of infected people during the COVID-19 pandemic? This study aims to clarify the correlation between home range and the number of people infected with SARS-CoV-2 during the COVID-19 pandemic in Ibaraki City. Home ranges are analyzed by the Minimum Convex Polygon method using mobile phone GPS location history data. We analyzed the time series cross-correlation between home range lengths and the number of infected people. Results reveal a slight positive correlation between home range and the number of infected people after one week during the COVID-19 pandemic. Regarding home range length, the cross-correlation coefficient is 0.4030 even at a lag level of six weeks, which has the most significant coefficient. Thus, a decrease in the home range is a weak factor correlated with a reduction in the number of infected people. This study makes a significant contribution to the literature by evaluating key public health challenges from the perspective of controliing the spread of the COVID-19 infectuion. Its findings has implications for policy makers, practitioners, and urban scientists seeking to promote urban sustainability.
Lire la suite »
Will We See a Winter COVID Surge, and How Could It Impact Holiday Travel?With COVID-19 cases surging in Europe and Asia, there are new concerns that the U.S. could see a similar spike just as we head into the holiday travel season. So should you book your travel plans now, or hold off until you see how the next few weeks go? We asked Boston doctors for their thoughts during NBC10 Boston’s weekly…
Lire la suite »
Current number of rising positive Covid cases in Leeds detailed in new Government dataNearly one in 40 people are estimated to have Covid in Leeds, according to most up-to-date figures.
Lire la suite »
Pathophysiological mechanisms of COVID-19-related endothelial dysfunction and potential therapiesResearchers discussed the pathophysiological mechanisms of endothelial dysfunction associated with severe coronavirus disease 2019 (COVID-19) and commented on the potential therapeutic strategies to treat endothelial damage and coagulopathy related to COVID-19.
Lire la suite »